Somatic mutations in the epidermal growth factor receptor (EGFR) is a driven oncogenic event found in 50% of Asian NSCLC patients and 10–15% of Caucasian patients [119,120]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.